CD9 monoclonal antibody-conjugated PEGylated liposomes for targeted delivery of rapamycin in the treatment of cellular senescence

Nanotechnology

Volumn 28, Issue 9, 2017, Pages

  Nguyen, Hanh Thuy ^a   Thapa, Raj Kumar ^a   Shin, Beom Soo ^b   Jeong, Jee Heon ^a   Kim, Jae Ryong ^c   Yong, Chul Soon ^a   Kim, Jong Oh ^a  

^a Yeungnam University   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

Author keywords

CD9 monoclonal antibody; liposome; premature senescence; rapamycin

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CELLS; CONTROLLED DRUG DELIVERY; LIPOSOMES; MONOCLONAL ANTIBODIES; PARTICLE SIZE;

CONFOCAL MICROSCOPIC IMAGE; HUMAN DERMAL FIBROBLASTS; LIPOSOMAL FORMULATION; NARROW SIZE DISTRIBUTIONS; NEGATIVE ZETA POTENTIALS; POLYDISPERSITY INDICES; PREMATURE SENESCENCE; RAPAMYCIN;

TARGETED DRUG DELIVERY;

BETA GALACTOSIDASE; CD9 ANTIGEN; CD9 PROTEIN, HUMAN; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; RAPAMYCIN;

CELL AGING; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DERMIS; DRUG EFFECT; FIBROBLAST; HUMAN; IMMUNOLOGY; METABOLISM; PARTICLE SIZE; ULTRASTRUCTURE; WOUND HEALING;

ANTIBODIES, MONOCLONAL; BETA-GALACTOSIDASE; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELLULAR SENESCENCE; DERMIS; FIBROBLASTS; HUMANS; LIPOSOMES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SIROLIMUS; TETRASPANIN-29; WOUND HEALING;

EID: 85011994113     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/1361-6528/aa57b3     Document Type: Article

References (53)

1. Bielak-Zmijewska A et al 2014 A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta Biogerontology 15 47-64
2. Toussaint O, Medrano E E and von Zglinicki T 2000 Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes Exp. Gerontol. 35 927-45
3. Kilic Eren M, Kilincli A and Eren O 2015 Resveratrol induced premature senescence is associated with DNA damage mediated SIRT1 and SIRT2 down-regulation PLoS One 10 e0124837
4. Kuilman T, Michaloglou C, Mooi W J and Peeper D S 2010 The essence of senescence Genes Dev. 24 2463-79
5. Maejima Y, Adachi S, Ito H, Hirao K and Isobe M 2008 Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage Aging Cell 7 125-36
6. Joyner D E, Bastar J D and Randall R L 2006 Doxorubicin induces cell senescence preferentially over apoptosis in the FU-SY-1 synovial sarcoma cell line J. Orthopaedic Res. : Official Pub. Orthopaedic Res. Soc. 24 1163-9
7. Laberge R M et al 2015 MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation Nat. Cell Biol. 17 1049-61
8. Yang M Y, Lin P M, Liu Y C, Hsiao H H, Yang W C, Hsu J F, Hsu C M and Lin S F 2012 Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells PLoS One 7 e37205
9. Kooijmans S S A, Vader P, van Dommelen S M, van Solinge W W and Schiffelers R M 2012 Exosome mimetics: a novel class of drug delivery systems Int. J. Nanomed. 7 1525-41
10. Parthasarathy V, Martin F, Higginbottom A, Murray H, Moseley G W, Read R C, Mal G, Hulme R, Monk P N and Partridge L J 2009 Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells Immunology 127 237-48
11. Zheng R, Yano S, Zhang H, Nakataki E, Tachibana I, Kawase I, Hayashi S and Sone S 2005 CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID mice Oncol. Res. 15 365-72
12. Kawakami K, Fujita Y, Kato T, Mizutani K, Kameyama K, Tsumoto H, Miura Y, Deguchi T and Ito M 2015 Integrin beta4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance Int. J. Oncol. 47 384-90
13. Zvereff V, Wang J C, Shun K, Lacoste J and Chevrette M 2007 Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells Br. J. Cancer 97 941-8
14. Kim T W, Kim H J, Lee C, Kim H Y, Baek S-H, Kim J H, Kwon K-S and Kim J-R 2008 Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system Exp. Gerontol. 43 286-95
15. Lafferty-Whyte K, Cairney C J, Jamieson N B, Oien K A and Keith W N 2009 Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms Biochim. Biophys. Acta (BBA) - Mol. Basis Disease 1792 341-52
16. Demidenko Z N, Shtutman M and Blagosklonny M V 2009 Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence Cell Cycle 8 1896-900
17. Demidenko Z N and Blagosklonny M V 2008 Growth stimulation leads to cellular senescence when the cell cycle is blocked Cell Cycle 7 3355-61
18. Demidenko Z N, Zubova S G, Bukreeva E I, Pospelov V A, Pospelova T V and Blagosklonny M V 2009 Rapamycin decelerates cellular senescence Cell Cycle 8 1888-95
19. Gu Z et al 2016 Rapamycin reverses the senescent phenotype and improves immuno-regulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway Aging 8 1102-14
20. Herranz N et al 2015 mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype Nat. Cell Biol. 17 1205-17
21. Kim J-S 2016 Liposomal drug delivery system J. Pharmaceutical Investigation 46 387-92
22. Vemuri S and Rhodes C T 1995 Preparation and characterization of liposomes as therapeutic delivery systems: a review Pharmaceutica Acta Helvetiae 70 95-111
23. Lee E S and Youn Y S 2016 Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation J. Pharmaceutical Investigation 46 305-15
24. Hafez I M and Cullis P R 2000 Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior Biochim. Biophys. Acta (BBA) - Biomembr. 1463 107-14
25. Nguyen H T, Tran T H, Thapa R K, Pham T T, Jeong J-H, Youn Y S, Choi H-G, Yong C S and Kim J O 2017 Incorporation of chemotherapeutic agent and photosensitizer in a low temperature-sensitive liposome for effective chemo-hyperthermic anticancer activity Expert Opin. Drug Deliv. 14 155-64
26. Basak S K et al 2015 Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells Oncotarget 6 18504-17
27. Ishida Y, Kiyokawa Y, Asai T and Oku N 2016 Ameliorating effects of sphingomyelin-based liposomes on sarcopenia in senescence-accelerated mice Biol. Pharmaceutical Bull. 39 786-93
28. Choi J Y et al 2016 PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy Acta Biomater. 39 94-105
29. Tsai C-P, Chen C-Y, Hung Y, Chang F-H and Mou C-Y 2009 Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells J. Mater. Chem. 19 5737-43
30. Goodall S, Jones M L and Mahler S 2015 Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects J. Chem. Technol. Biotechnol. 90 1169-76
31. Kumar S, Aaron J and Sokolov K 2008 Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties Nat. Protocols 3 314-20
32. Nguyen H T, Tran T H, Kim J O, Yong C S and Nguyen C N 2015 Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-d,l-lactide-co-glycolide (PLGA) nanoparticles Arch. Pharmacal Res. 38 716-24
33. Thapa R K, Nguyen H T, Jeong J-H, Shin B S, Ku S K, Choi H-G, Yong C S and Kim J O Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers Nanomed.: Nanotechnol. Biol. Med.
34. Tran T H, Nguyen H T, Pham T T, Choi J Y, Choi H-G, Yong C S and Kim J O 2015 Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer ACS Appl. Mater. Interfaces 7 28647-55
35. Islambulchilar Z, Ghanbarzadeh S, Emami S, Valizadeh H and Zakeri-Milani P 2012 Development and validation of an HPLC method for the analysis of sirolimus in drug products Adv. Pharmaceutical Bull. 2 135-9
36. Hsiao I L and Huang Y-J 2013 Effects of serum on cytotoxicity of nano- and micro-sized ZnO particles J. Nanopart. Res. 15 1829
37. Yin T, Dong L, Cui B, Wang L, Yin L, Zhou J and Huo M 2015 A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy Int. J. Nanomed. 10 7397-412
38. Rebbaa A, Zheng X, Chou P M and Mirkin B L 2003 Caspase inhibition switches doxorubicin-induced apoptosis to senescence Oncogene 22 2805-11
39. Bae Y U, Choi J H, Nagy A, Sung H K and Kim J R 2016 Antisenescence effect of mouse embryonic stem cell conditioned medium through a PDGF/FGF pathway FASEB J. 30 1276-86
40. Debacq-Chainiaux F, Erusalimsky J D, Campisi J and Toussaint O 2009 Protocols to detect senescence-associated beta-galactosidase (SA-[beta]gal) activity, a biomarker of senescent cells in culture and in vivo Nat. Protocols 4 1798-806
41. Lee B Y, Han J A, Im J S, Morrone A, Johung K, Goodwin E C, Kleijer W J, DiMaio D and Hwang E S 2006 Senescence-associated beta-galactosidase is lysosomal beta-galactosidase Aging Cell 5 187-95
42. Itahana K, Itahana Y and Dimri G P 2013 Colorimetric detection of senescence-associated β galactosidase Methods Mol. Biol. 965 143-56
43. Sarsour E H, Kumar M G, Chaudhuri L, Kalen A L and Goswami P C 2009 Redox control of the cell cycle in health and disease Antioxidants Redox Signaling 11 2985-3011
44. Lee S J, Cho S C, Lee E J, Kim S, Lee S B, Lim J H, Choi Y H, Kim W J and Moon S K 2013 Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-kappaB) activation by inducing the up-regulation of p21(WAF1) protein expression J. Biol. Chem. 288 5539-52
45. Hinojosa C A, Mgbemena V, Van Roekel S, Austad S N, Miller R A, Bose S and Orihuela C J 2012 Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence Exp. Gerontol. 47 958-65
46. Hong S-S, Kim S H and Lim S-J 2015 Effects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomes Int. J. Pharm. 483 142-50
47. Liao E C, Hsu Y T, Chuah Q Y, Lee Y J, Hu J Y, Huang T C, Yang P M and Chiu S J 2014 Radiation induces senescence and a bystander effect through metabolic alterations Cell Death Dis. 5 e1255
48. Unterluggauer H, Mazurek S, Lener B, Hutter E, Eigenbrodt E, Zwerschke W and Jansen-Durr P 2008 Premature senescence of human endothelial cells induced by inhibition of glutaminase Biogerontology 9 247-59
49. Gillespie Z E, MacKay K, Sander M, Trost B, Dawicki W, Wickramarathna A, Gordon J, Eramian M, Kill I R and Bridger J M 2015 Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production Nucleus 6 490-506
50. Campisi J and d'Adda di Fagagna F 2007 Cellular senescence: when bad things happen to good cells Nat. Rev. Mol. Cell Biol. 8 729-40
51. Telgenhoff D and Shroot B 2005 Cellular senescence mechanisms in chronic wound healing Cell Death Differ. 12 695-8
52. Jun J I and Lau L F 2010 The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing Nat. Cell Biol. 12 676-85
53. Ruiz-Torres A, Lozano R, Melon J and Carraro R 2003 Age-dependent decline of in vitro migration (basal and stimulated by IGF-1 or insulin) of human vascular smooth muscle cells J. Gerontol. A 58 B1074-7